PL2435406T3 - Rozdzielanie (±)-fenylo[4-[4-[[[4'-(trifluorometylo)-2-bifenylilo]karbonylo]amino]fenylo]-1-piperydynylo] octanu metylu - Google Patents
Rozdzielanie (±)-fenylo[4-[4-[[[4'-(trifluorometylo)-2-bifenylilo]karbonylo]amino]fenylo]-1-piperydynylo] octanu metyluInfo
- Publication number
- PL2435406T3 PL2435406T3 PL10724047T PL10724047T PL2435406T3 PL 2435406 T3 PL2435406 T3 PL 2435406T3 PL 10724047 T PL10724047 T PL 10724047T PL 10724047 T PL10724047 T PL 10724047T PL 2435406 T3 PL2435406 T3 PL 2435406T3
- Authority
- PL
- Poland
- Prior art keywords
- phenyl
- biphenylyl
- piperidinyl
- trifluoromethyl
- carbonyl
- Prior art date
Links
- WSYALRNYQFNNGP-UHFFFAOYSA-N methyl 2-phenyl-2-[4-[4-[[2-[4-(trifluoromethyl)phenyl]benzoyl]amino]phenyl]piperidin-1-yl]acetate Chemical compound C=1C=CC=CC=1C(C(=O)OC)N(CC1)CCC1C(C=C1)=CC=C1NC(=O)C1=CC=CC=C1C1=CC=C(C(F)(F)F)C=C1 WSYALRNYQFNNGP-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09161460 | 2009-05-29 | ||
| PCT/EP2010/057319 WO2010136526A1 (en) | 2009-05-29 | 2010-05-27 | Resolution of (±)-methyl phenyl[4-[4-[[[4'-(trifluoromethyl)-2-biphenylyl]carbonyl]amino]phenyl]-1-piperidinyl]acetate |
| EP10724047A EP2435406B1 (en) | 2009-05-29 | 2010-05-27 | Resolution of (±)-methyl phenyl[4-[4-[[[4'-(trifluoromethyl)-2-biphenylyl]carbonyl]amino]phenyl]-1-piperidinyl]acetate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2435406T3 true PL2435406T3 (pl) | 2013-07-31 |
Family
ID=40973200
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL10724047T PL2435406T3 (pl) | 2009-05-29 | 2010-05-27 | Rozdzielanie (±)-fenylo[4-[4-[[[4'-(trifluorometylo)-2-bifenylilo]karbonylo]amino]fenylo]-1-piperydynylo] octanu metylu |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US8461341B2 (pl) |
| EP (1) | EP2435406B1 (pl) |
| JP (1) | JP5596134B2 (pl) |
| KR (1) | KR101658880B1 (pl) |
| CN (1) | CN102448934B (pl) |
| AU (1) | AU2010251910B2 (pl) |
| CA (1) | CA2757702C (pl) |
| CY (1) | CY1114406T1 (pl) |
| DK (1) | DK2435406T3 (pl) |
| EA (1) | EA018296B1 (pl) |
| ES (1) | ES2412081T3 (pl) |
| HR (1) | HRP20130393T1 (pl) |
| PL (1) | PL2435406T3 (pl) |
| PT (1) | PT2435406E (pl) |
| SI (1) | SI2435406T1 (pl) |
| WO (1) | WO2010136526A1 (pl) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8329869D0 (en) * | 1983-11-09 | 1983-12-14 | Janssen Pharmaceutica Nv | Isolating levamisole from tetramisole |
| JO2654B1 (en) * | 2000-09-04 | 2012-06-17 | شركة جانسين فارماسوتيكا ان. في | Multiple aryl caroxa amides are useful as lipid - lowering agents |
| JO2390B1 (en) | 2001-04-06 | 2007-06-17 | شركة جانسين فارماسوتيكا ان. في | Diphenylcarboxamides act as lipid-lowering agents |
-
2010
- 2010-05-27 SI SI201030201T patent/SI2435406T1/sl unknown
- 2010-05-27 US US13/322,575 patent/US8461341B2/en not_active Expired - Fee Related
- 2010-05-27 CA CA2757702A patent/CA2757702C/en not_active Expired - Fee Related
- 2010-05-27 JP JP2012512376A patent/JP5596134B2/ja active Active
- 2010-05-27 CN CN201080024606.9A patent/CN102448934B/zh not_active Expired - Fee Related
- 2010-05-27 HR HRP20130393AT patent/HRP20130393T1/hr unknown
- 2010-05-27 ES ES10724047T patent/ES2412081T3/es active Active
- 2010-05-27 DK DK10724047.5T patent/DK2435406T3/da active
- 2010-05-27 AU AU2010251910A patent/AU2010251910B2/en not_active Ceased
- 2010-05-27 PT PT107240475T patent/PT2435406E/pt unknown
- 2010-05-27 PL PL10724047T patent/PL2435406T3/pl unknown
- 2010-05-27 KR KR1020117027430A patent/KR101658880B1/ko not_active Expired - Fee Related
- 2010-05-27 EP EP10724047A patent/EP2435406B1/en active Active
- 2010-05-27 EA EA201171476A patent/EA018296B1/ru not_active IP Right Cessation
- 2010-05-27 WO PCT/EP2010/057319 patent/WO2010136526A1/en not_active Ceased
-
2013
- 2013-06-06 CY CY20131100450T patent/CY1114406T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20120071660A1 (en) | 2012-03-22 |
| EP2435406A1 (en) | 2012-04-04 |
| ES2412081T3 (es) | 2013-07-10 |
| JP2012528118A (ja) | 2012-11-12 |
| JP5596134B2 (ja) | 2014-09-24 |
| CN102448934B (zh) | 2014-04-02 |
| DK2435406T3 (da) | 2013-05-13 |
| SI2435406T1 (sl) | 2013-06-28 |
| EP2435406B1 (en) | 2013-03-06 |
| HRP20130393T1 (hr) | 2013-05-31 |
| CA2757702A1 (en) | 2010-12-02 |
| AU2010251910A1 (en) | 2011-11-03 |
| CY1114406T1 (el) | 2016-08-31 |
| PT2435406E (pt) | 2013-05-08 |
| AU2010251910B2 (en) | 2014-07-10 |
| KR20120016246A (ko) | 2012-02-23 |
| EA201171476A1 (ru) | 2012-05-30 |
| CA2757702C (en) | 2016-10-11 |
| US8461341B2 (en) | 2013-06-11 |
| CN102448934A (zh) | 2012-05-09 |
| KR101658880B1 (ko) | 2016-09-30 |
| WO2010136526A1 (en) | 2010-12-02 |
| EA018296B1 (ru) | 2013-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL276157A (en) | Pharmaceutical preparations and methods for transferring them related to them | |
| IL206201A (en) | Salts of 2– {4 - [(3s) - piperidine – 3 – ram] phenyl} –2 h– indazole-7-carboxamide-compatible pharmaceuticals and their uses | |
| ZA201007522B (en) | Methods and compositions for oral administration of proteins | |
| IL221795A0 (en) | Formulations for parenteral delivery of compounds and uses thereof | |
| IL202680A0 (en) | Formulations of nonopioid and confined opioid analgesics | |
| IL206835A0 (en) | Methods and compositions for oral administration of insulin | |
| IL231463A0 (en) | Carboxamide compounds and its use in the preparation of a medicine | |
| IL209431A0 (en) | Novel salts of (4-{[(5-{[(3-chlorophenyl)methyl]oxy}-2-methylphenyl)carbonyl]amino}-3-methylphenyl)acetic acid | |
| IL208794A0 (en) | Oral administration of peripherally-acting opioid antagonists | |
| IL232457A0 (en) | Quinolone compound and pharmaceutical preparation | |
| SI2223684T1 (sl) | Farmacevtski sestavek s podaljšanim sproščanjem oktreotidnega acetata | |
| IL201894A (en) | A quinolone compound and a @pharmaceutical containing @ | |
| EP2152232A4 (en) | METHOD AND COMPOSITIONS FOR OXYBUTYNINE ADMINISTRATION | |
| IL205309A (en) | Induced compounds of indzole carbonyl amino amino methyl piperidine ethyl benzylic acid, their preparation and preparations containing them | |
| PL2435406T3 (pl) | Rozdzielanie (±)-fenylo[4-[4-[[[4'-(trifluorometylo)-2-bifenylilo]karbonylo]amino]fenylo]-1-piperydynylo] octanu metylu | |
| IL245352A0 (en) | Methods and preparations for administering proteins orally | |
| IL208165A0 (en) | Methods and compositions for oral administration of proteins | |
| IL210842A0 (en) | Methods and compositions for oral administration of proteins | |
| IL198994A0 (en) | Use of incensole and incensole acetate for the preparation of pharmaceutical compositions |